Gilead Sciences, Inc (GILD) current stock price is $120.47. During the last trading session, the stock soared, reaching $143.0 after opening at $120.47. The stock’s lowest point was $91.0 before it closed at $119.41.
Gilead Sciences, Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $121.38 on 08/08/25, and the lowest price during the same period was recorded at $72.43 on 08/12/24.
52-week price history of GILD Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Gilead Sciences, Inc’s current trading price is -0.75% away from its 52-week high, while its distance from the 52-week low is 66.33%. The stock’s price range for this period has remained between $72.43 and $121.38. The Healthcare sector company’s shares managed to surpass a trading volume of around 7.04 million for the day, which was noticeably lower compared to the shares’ average daily volume of 7.69 million over the last three months.
Financial Performance and Market Capitalization
Gilead Sciences, Inc (GILD) has experienced a quarterly rise of 24.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 149.48B and boasts a workforce of 17600 employees.
Analysts’ Ratings For Gilead Sciences, Inc
As of right now, 16 analysts are rating Gilead Sciences, Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 9 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 108.37, with a change in price of +10.24. Similarly, Gilead Sciences, Inc recorded 8,488,621 in trading volume during the last 100 days, posting a change of +9.29%.
GILD Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for GILD stands at 1.27. Similarly, the long-term debt-to-equity ratio is also 1.13.
GILD Stock Stochastic Average
As of today, the raw stochastic average of Gilead Sciences, Inc over the past 50 days is 94.62%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 93.32%. Additionally, the Stochastic %K and %D values for the company were 68.19% and 48.96%, respectively, over the past 20 days.
GILD Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 62.80%. However, over the last six months, the performance has been weaker by 25.44%. The price of GILD increased 9.88% over the last 30 days. And in the last five days, it has surged by 5.20%.
